PL2822552T3 - Leczenie menopauzalnych uderzeń gorąca z ropinirole i tizanidine - Google Patents

Leczenie menopauzalnych uderzeń gorąca z ropinirole i tizanidine

Info

Publication number
PL2822552T3
PL2822552T3 PL13757880T PL13757880T PL2822552T3 PL 2822552 T3 PL2822552 T3 PL 2822552T3 PL 13757880 T PL13757880 T PL 13757880T PL 13757880 T PL13757880 T PL 13757880T PL 2822552 T3 PL2822552 T3 PL 2822552T3
Authority
PL
Poland
Prior art keywords
tizanidine
ropinirole
treatment
hot flashes
menopausal hot
Prior art date
Application number
PL13757880T
Other languages
English (en)
Inventor
Robert L. Knobler
Original Assignee
Robert L. Knobler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert L. Knobler filed Critical Robert L. Knobler
Publication of PL2822552T3 publication Critical patent/PL2822552T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13757880T 2012-03-05 2013-03-02 Leczenie menopauzalnych uderzeń gorąca z ropinirole i tizanidine PL2822552T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/411,660 US9616123B1 (en) 2012-03-05 2012-03-05 Method and compound for treatment of menopausal symptoms
EP13757880.3A EP2822552B1 (en) 2012-03-05 2013-03-02 Treatment of menopausal hot flashes with ropinirole and tizanidine
PCT/US2013/028773 WO2013134080A2 (en) 2012-03-05 2013-03-02 Improved method and compound for treatment of menopausal symptoms

Publications (1)

Publication Number Publication Date
PL2822552T3 true PL2822552T3 (pl) 2018-10-31

Family

ID=49117484

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13757880T PL2822552T3 (pl) 2012-03-05 2013-03-02 Leczenie menopauzalnych uderzeń gorąca z ropinirole i tizanidine

Country Status (16)

Country Link
US (3) US9616123B1 (pl)
EP (1) EP2822552B1 (pl)
CY (1) CY1120178T1 (pl)
DK (1) DK2822552T3 (pl)
ES (1) ES2667057T3 (pl)
HR (1) HRP20180620T1 (pl)
HU (1) HUE037138T2 (pl)
IL (1) IL234494B (pl)
LT (1) LT2822552T (pl)
NO (1) NO2941251T3 (pl)
PL (1) PL2822552T3 (pl)
PT (1) PT2822552T (pl)
RS (1) RS57150B1 (pl)
SI (1) SI2822552T1 (pl)
SM (1) SMT201800209T1 (pl)
WO (1) WO2013134080A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11903926B1 (en) * 2012-03-05 2024-02-20 Iris International Pharma, LLC Non-hormonal treatment of hot flashes
US11537994B2 (en) * 2018-11-29 2022-12-27 International Business Machines Corporation Mitigating disruptive effects of detected diminished working capacity
CA3137710A1 (en) * 2019-04-22 2020-10-29 Robert L. Knobler Non-hormonal treatment of hot flashes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL53452A (en) * 1976-11-30 1980-12-31 Pierpaoli W Combination of drugs for the selective control of immune reactions
US20020172732A1 (en) * 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa
PL1691811T3 (pl) * 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
DK1742624T3 (da) * 2004-02-18 2010-03-08 Sepracor Inc Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
CA2611216A1 (en) * 2005-06-15 2006-12-21 Pfizer Limited 3-phenylazetidine derivatives as dopamine agonists
WO2007005940A2 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and didesmethylsibutramine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
EP2175840A2 (en) * 2007-08-14 2010-04-21 Dr. Reddy's Laboratories, Ltd. Pharmaceutical compositions comprising ropinirole
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US20100298305A1 (en) * 2008-11-26 2010-11-25 The United States Government, As Represented By The Department Of Veterans Affairs Tizanidine for the treatment of post-traumatic stress disorder and nightmares
WO2011109367A2 (en) * 2010-03-02 2011-09-09 Royster Jr George E Methods and compositions for treating or preventing symptoms of hormonal variations

Also Published As

Publication number Publication date
DK2822552T3 (en) 2018-05-07
EP2822552A2 (en) 2015-01-14
NO2941251T3 (pl) 2018-08-04
SI2822552T1 (en) 2018-06-29
EP2822552B1 (en) 2018-01-31
CA2866494A1 (en) 2013-09-12
EP2822552A4 (en) 2015-06-17
LT2822552T (lt) 2018-05-25
PT2822552T (pt) 2018-05-07
US10806722B1 (en) 2020-10-20
HUE037138T2 (hu) 2018-08-28
SMT201800209T1 (it) 2018-07-17
HRP20180620T1 (hr) 2018-08-10
US9616123B1 (en) 2017-04-11
ES2667057T3 (es) 2018-05-09
RS57150B1 (sr) 2018-07-31
US9468631B1 (en) 2016-10-18
CY1120178T1 (el) 2018-12-12
WO2013134080A3 (en) 2013-12-27
WO2013134080A2 (en) 2013-09-12
IL234494B (en) 2020-05-31

Similar Documents

Publication Publication Date Title
SG11201405361SA (en) Automatic regulation of therapy based on radiometry and temperature
SG11201509012QA (en) Sobetirome in the treatment of myelination diseases
GB201320723D0 (en) Composition and methods of treatment
EP2833087A4 (en) DEVICE FOR PROVIDING COLD AND HOT STERILIZED WATER
IL234581B (en) Systems for heating with amplified microwaves and methods for using them
IL239637A0 (en) Human or large mammal lung bioreactor
GB2516343B (en) Improvements in and relating to ophthalmoscopes
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
EP2808635A4 (en) DRY OVEN UNIT AND DRY OVEN
GB201217027D0 (en) Near live-migration of operating system and application
PL2822964T3 (pl) Identyfikacja mutacji opsyny kanałowej 2 (chop2) i sposoby stosowania
GB2509710B (en) Photobioreactor and its use in waste water treatment
GB2499253B (en) Heater and method of operation therefor
GB201317513D0 (en) Apparatus for the provision of hot water and/or heating
IL233625A0 (en) Enaminoketones containing cf3o and their use for the preparation of pyrazoles containing cf3o
PT2970854T (pt) Biorreator de câmara dupla rotacional: métodos e usos do mesmo
IL245604A0 (en) Combination treatment of anti-mif antibodies and chemotherapeutic agents
SMT201800209T1 (it) Trattamento di vampate di calore di menopausa con ropinirolo e tizanidina
GB2498237B (en) Sports suit with heating system and kit of parts therefor
EP2934501A4 (en) USES AND METHOD FOR THE TREATMENT OF LIVER DISEASES OR DRESSES
EP2809285A4 (en) HYPERBARE CHAMBER SYSTEM AND ASSOCIATED METHODS
GB201204981D0 (en) Pre-harvest treatment
SG11201601263WA (en) Recombinant microorganisms and methods of use thereof
GB201304038D0 (en) Treated cells and therapeutic uses
ZA201408128B (en) Etract of greyia radlkoferi and use thereof